Skip Navigation


International Immunology Advance Access originally published online on December 16, 2005
International Immunology 2006 18(2):269-277; doi:10.1093/intimm/dxh366
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/2/269    most recent
dxh366v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, S.
Right arrow Articles by Sugamura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, S.
Right arrow Articles by Sugamura, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells

Shuming Chen1, Naoto Ishii1, Shouji Ine1, Syuichi Ikeda2, Taku Fujimura3, Lishomwa C. Ndhlovu1, Pejman Soroosh1, Kohtaro Tada1, Hideo Harigae4, Junichi Kameoka4, Noriyuki Kasai5, Takeshi Sasaki4 and Kazuo Sugamura1

1 Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
2 Sasebo City General Hospital, Sasebo 857-8511, Japan
3 Department of Dermatology, 4 Department of Rheumatology and Hematology and 5 Institute for Animal Experimentation, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan

Correspondence to: N. Ishii; E-mail: ishiin{at}mail.tains.tohoku.ac.jp

Adult T cell leukemia (ATL) is an aggressive neoplastic disease, in which a quarter of the patients develop opportunistic infections due to cellular immunodeficiency. However, the underlying mechanism responsible for the immunosuppression has remained unclear. Recent studies have demonstrated that the leukemia cells from a subset of patients with ATL express Foxp3, a specific marker for CD25+CD4+ regulatory T (Treg) cells, which regulate the immune response by suppressing CD4+ T cell functions. However, whether there is a functional resemblance between ATL cells that have Foxp3 expression and Treg cells is still unknown. In this report, we confirmed the high expression of Foxp3 in leukemia cells from 5 of 12 ATL patients and demonstrated that ATL cells from 3 patients suppressed the proliferation of CD4+ T cells. Similarly, one of six HTLV-I-infected cell lines showed both high Foxp3 expression and suppressive activity. Like Treg cells, the suppression induced by the ATL cells from two patients and the HTLV-infected cell line appeared to be mediated by a cell–cell contact-dependent mechanism. Nevertheless, among the ATL cells that strongly expressed Foxp3, those from two of the five patients showed no apparent suppressive activity. Furthermore, retroviral transfection of Foxp3 did not confer any suppressive function on low Foxp3-expressing HTLV-I-infected cell lines. These results indicate that Foxp3 may be essential but is not sufficient for the Treg-cell-like suppressive activity of ATL cells and HTLV-I-infected cell lines.

Keywords: ATL, Foxp3, HTLV-I, regulatory T cell

Transmitting editor: T. Saito


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
N. Takatsuka, A. Hasegawa, A. Takamori, Y. Shimizu, H. Kato, T. Ohashi, T. Amagasa, T. Masuda, and M. Kannagi
Induction of IL-10- and IFN-{gamma}-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax
Int. Immunol., September 1, 2009; 21(9): 1089 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. F. Mousavi, P. Soroosh, T. Takahashi, Y. Yoshikai, H. Shen, L. Lefrancois, J. Borst, K. Sugamura, and N. Ishii
OX40 Costimulatory Signals Potentiate the Memory Commitment of Effector CD8+ T Cells
J. Immunol., November 1, 2008; 181(9): 5990 - 6001.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H.-P. Kim and W. J. Leonard
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation
J. Exp. Med., July 9, 2007; 204(7): 1543 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Komori, A. Hasegawa, K. Kurihara, T. Honda, H. Yokozeki, T. Masuda, and M. Kannagi
Reduction of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Loads in Rats Orally Infected with HTLV-1 by Reimmunization with HTLV-1-Infected Cells.
J. Virol., August 1, 2006; 80(15): 7375 - 7381.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.